Brief: Egetis - European Thyroid Association Recommends Tiratricol (Emcitate) In New Guidelines
17/07/2024 07:54
July 17 (Reuters) - Egetis Therapeutics AB (publ)
EGTX.ST :
* EUROPEAN THYROID ASSOCIATION RECOMMENDS TIRATRICOL
(EMCITATE) AS
LONG-TERM THERAPY FOR ALL PATIENTS WITH MCT8 DEFICIENCY IN NEW
GUIDELINES
Source text for Eikon: ID:nMFNNtY4m
Further company coverage: EGTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))